50
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Quantitative Multigene FISH on Breast Carcinomas Identifies der(1;16)(q10;p10) as an Early Event in Luminal A Tumors

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In situ detection of genomic alterations in cancer provides information at the single cell level, making it possible to investigate genomic changes in cells in a tissue context. Such topological information is important when studying intratumor heterogeneity as well as alterations related to different steps in tumor progression. We developed a quantitative multigene fluorescence in situ hybridization (QM FISH) method to detect multiple genomic regions in single cells in complex tissues. As a “proof of principle” we applied the method to breast cancer samples to identify partners in whole arm (WA) translocations. WA gain of chromosome arm 1q and loss of chromosome arm 16q are among the most frequent genomic events in breast cancer. By designing five specific FISH probes based on breakpoint information from comparative genomic hybridization array (aCGH) profiles, we visualized chromosomal translocations in clinical samples at the single cell level. By analyzing aCGH data from 295 patients with breast carcinoma with known molecular subtype, we found concurrent WA gain of 1q and loss of 16q to be more frequent in luminal A tumors compared to other molecular subtypes. QM FISH applied to a subset of samples ( n = 26) identified a derivative chromosome der(1;16)(q10;p10), a result of a centromere-close translocation between chromosome arms 1q and 16p. In addition, we observed that the distribution of cells with the translocation varied from sample to sample, some had a homogenous cell population while others displayed intratumor heterogeneity with cell-to-cell variation. Finally, for one tumor with both preinvasive and invasive components, the fraction of cells with translocation was lower and more heterogeneous in the preinvasive tumor cells compared to the cells in the invasive component. © 2014 The Authors Genes, Chromosomes & Cancer Published by Wiley Periodicals, Inc.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: not found
          • Book: not found

          Molecular Cloning : A Laboratory Manual

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            COMPLEX LANDSCAPES OF SOMATIC REARRANGEMENT IN HUMAN BREAST CANCER GENOMES

            SUMMARY Multiple somatic rearrangements are often found in cancer genomes. However, the underlying processes of rearrangement and their contribution to cancer development are poorly characterised. Here, we employed a paired-end sequencing strategy to identify somatic rearrangements in breast cancer genomes. There are more rearrangements in some breast cancers than previously appreciated. Rearrangements are more frequent over gene footprints and most are intrachromosomal. Multiple architectures of rearrangement are present, but tandem duplications are common in some cancers, perhaps reflecting a specific defect in DNA maintenance. Short overlapping sequences at most rearrangement junctions suggest that these have been mediated by non-homologous end-joining DNA repair, although varying sequence patterns indicate that multiple processes of this type are operative. Several expressed in-frame fusion genes were identified but none were recurrent. The study provides a new perspective on cancer genomes, highlighting the diversity of somatic rearrangements and their potential contribution to cancer development.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.

              Breast cancer is a leading cause of cancer-death among women, where the clinicopathological features of tumors are used to prognosticate and guide therapy. DNA copy number alterations (CNAs), which occur frequently in breast cancer and define key pathogenetic events, are also potentially useful prognostic or predictive factors. Here, we report a genome-wide array-based comparative genomic hybridization (array CGH) survey of CNAs in 89 breast tumors from a patient cohort with locally advanced disease. Statistical analysis links distinct cytoband loci harboring CNAs to specific clinicopathological parameters, including tumor grade, estrogen receptor status, presence of TP53 mutation, and overall survival. Notably, distinct spectra of CNAs also underlie the different subtypes of breast cancer recently defined by expression-profiling, implying these subtypes develop along distinct genetic pathways. In addition, higher numbers of gains/losses are associated with the "basal-like" tumor subtype, while high-level DNA amplification is more frequent in "luminal-B" subtype tumors, suggesting also that distinct mechanisms of genomic instability might underlie their pathogenesis. The identified CNAs may provide a basis for improved patient prognostication, as well as a starting point to define important genes to further our understanding of the pathobiology of breast cancer. This article contains Supplementary Material available at http://www.interscience.wiley.com/jpages/1045-2257/suppmat (c) 2006 Wiley-Liss, Inc.
                Bookmark

                Author and article information

                Journal
                Genes Chromosomes Cancer
                Genes Chromosomes Cancer
                gcc
                Genes, Chromosomes & Cancer
                BlackWell Publishing Ltd (Oxford, UK )
                1045-2257
                1098-2264
                April 2015
                26 December 2014
                : 54
                : 4
                : 235-248
                Affiliations
                [1 ]Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0424, Oslo, 0310, Norway
                [2 ]The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo Oslo, Norway
                [3 ]Department of Oncology–Pathology, Karolinska Institutet, Cancer Center Karolinska SE-171 76, Stockholm, Sweden
                [4 ]Department of Pathology, Oslo University Hospital Radiumhospitalet, 0424, Oslo, Norway
                [5 ]Department of Oncology, Oslo University Hospital Radiumhospitalet, 0424, Oslo, Norway
                [6 ]Cold Spring Harbor Laboratory, Cold Spring Harbor New York, 11724, USA
                Author notes
                * Correspondence to: Hege G. Russnes. Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, 0424 Oslo, Norway. E-mail: hegrus@ 123456rr-research.no

                Supported by: Norwegian Cancer Society (H.G.R.); Helse Sør-Øst (I.H.R.); Radiumhospital Foundation (H.G.R. and I.H.R.); ALBD from The Norwegian Cancer Society, HSØ; K.G. Jebsen Foundation; Swedish Cancer Society, Grant number: 100651-2010 (A.Z., P.L., S.M.); Swedish Research Council, Grant number: K2009-66X; The Cancer Society of Stockholm, Grant number: 131282-2013; Dept. of the Army, Grant number: W81XWH-11-1-0747 (M.W.); The Breast Cancer Research Foundation, M.W. is an American Cancer Society Research Professor.

                Inga H. Rye and Pär Lundin shared first authorship.

                Anders Zetterberg and Hege G. Russnes contributed equally to this work.

                Article
                10.1002/gcc.22237
                4369137
                25546585
                91a82feb-1f40-40f6-8a41-e2eb028d8f3d
                © 2014 The Authors Genes, Chromosomes & Cancer Published by Wiley Periodicals, Inc.

                This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

                History
                : 22 July 2014
                : 09 December 2014
                : 10 December 2014
                Categories
                Research Articles

                Oncology & Radiotherapy
                Oncology & Radiotherapy

                Comments

                Comment on this article